Medicines Board backs Seroxat manufacturer’s defence of drug

The Irish Medicines Board today backed claims by the manufacturer of an anti-depressant that the benefits outweighed the risks.

Norwegian research suggests that adults who take Seroxat are being warned it can trigger suicidal feelings, while Makers GlaxoSmithKline are defending the drug.